FLPKX | GVCIX | FLPKX / GVCIX | |
Total Expense Ratio | 0.79 | 1.00 | 79% |
Annual Report Gross Expense Ratio | 0.79 | 1.20 | 66% |
Fund Existence | 17 years | 18 years | - |
Gain YTD | 2.260 | 21.443 | 11% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 50000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.7B | 229M | 10,349% |
Annual Yield % from dividends | 1.92 | 0.85 | 227% |
Returns for 1 year | -5.92 | 9.65 | -61% |
Returns for 3 years | -0.82 | 12.32 | -7% |
Returns for 5 years | 0.67 | 1.01 | 66% |
Returns for 10 years | -8.07 | -26.82 | 30% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HQL | 16.84 | 0.34 | +2.06% |
abrdn Life Sciences Investors | |||
JPSV | 57.74 | 0.78 | +1.38% |
JPMorgan Active Small Cap Value ETF | |||
GUNR | 43.95 | 0.40 | +0.92% |
FlexShares Mstar Glbl Upstrm Nat Res ETF | |||
SEPM | 31.53 | 0.06 | +0.20% |
FT Vest U.S. Eq Max Buffr ETF - Sep | |||
RWM | 16.38 | -0.32 | -1.92% |
ProShares Short Russell2000 |